Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review

Clinical research in high-income countries is increasingly demonstrating the cost- effectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of adverse drug reactions and improving overall patient care. Medications are prescribed based on an individual’s genotype (pharmacogen...

Descripción completa

Detalles Bibliográficos
Autores principales: B. Tata, Emiliene, A. Ambele, Melvin, S. Pepper, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560181/
https://www.ncbi.nlm.nih.gov/pubmed/32858798
http://dx.doi.org/10.3390/pharmaceutics12090809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560181/
https://www.ncbi.nlm.nih.gov/pubmed/32858798
http://dx.doi.org/10.3390/pharmaceutics12090809

Ejemplares similares